-- American Eagle, Biogen, General Motors, Thor, Quest: U.S. Equity Preview
-- B y   I n y o u n g   H w a n g
-- 2012-01-20T22:35:56Z
-- http://www.bloomberg.com/news/2012-01-20/american-eagle-general-motors-thor-quest-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading on Jan. 23. Stock symbols
are in parentheses, and prices are as of 5 p.m. in  New York .  American Eagle Outfitters Inc. (AEO)   fell 0.7 percent to
$13.71. Chief Executive Officer James O’Donnell will resign from
the teen retailer. The Pittsburgh-based company named Jay
Schottenstein executive chairman.  General Motors Co. (GM)  : The National Highway Traffic
Safety Administration closed its battery safety investigation of
the automaker’s Chevy Volts, saying it doesn’t believe they or
other electric vehicles pose a greater risk of fire than
gasoline-powered vehicles.  Legacy Reserves LP (LGCY)  : The Midland, Texas-based oil
company boosted its quarterly dividend to 55 cents a share from
54.5 cents.  Thor Industries Inc. (THO)  : The recreational-vehicle
maker said it agreed to repurchase 1 million shares at $28.50
each in a private transaction from the estate of Wade F.B.
Thompson, co-founder and former chief executive officer of the
company.  Quest Diagnostics Inc. (DGX)  (DGX US): The Food and Drug
Administration authorized the biggest U.S. operator of medical
laboratories to offer a new test for infection risk in multiple
sclerosis patients taking Elan Corp. (ELN ID) and  Biogen Idec
Inc. (BIIB) ’s Tysabri drug.  Separately, Elan and  Biogen Idec  won U.S. clearance to
modify the label of Tysabri with new safety information that may
double the treatment’s worldwide sales.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 